Elucidating the exact pharmacological mechanism of action (MOA) of Obviously occurring compounds could be difficult. Although Tarselli et al. (60) designed the main de novo synthetic pathway to conolidine and showcased this Normally transpiring compound efficiently suppresses responses to both chemically induced and inflammation-derived agony, the